Table 1 Baseline clinical characteristics of the study population
Demographic characteristics | Total n = 60 patients | AVR n = 30 Patients | MVR n = 30 Patients |
|---|---|---|---|
Age (years), (mean ± SD) | 53.95 ± 12.09 | 59.83 ± 8.33 | 48.57 ± 12.63 |
Age groups, n (%) | |||
≤ 60 years | 40 (66.67) | 17 (56.67) | 23 (76.67) |
61–70 years | 19 (31.67) | 12 (40.0) | 7 (23.33) |
> 70 years | 1 (1.67) | 1 (3.33) | 0 (0.00) |
Gender, n (%) | |||
Male | 33 (55) | 21 (70) | 12 (40) |
Female | 27 (45) | 9 (30) | 18 (60) |
Body mass index (kg/m2), (mean ± SD) | 23.15 ± 4.83 | 24.16 ± 4.41 | 21.58 ± 4.35 |
STS risk of mortality, % (mean ± SD) | – | 1.18 ± 0.63 | 1.38 ± 0.82 |
Cardiopulmonary bypass time (minutes), (mean ± SD) | 129.56 ± 45.72 | 148.77 ± 62.81 | 114.69 ± 27.01 |
Co-morbidities, n (%) | |||
Smokers | 4 (6.67) | 3 (10) | 1 (3.33) |
Diabetes mellitus | 5 (8.33) | 4 (13.33) | 1 (3.33) |
Hypertension | 13 (21.67) | 9 (30) | 4 (13.33) |
Previous Cardiac events/surgeries | |||
Previous MI | 1 (1.67) | 1 (3.33) | 0 (0.00) |
Previous PCI | 1 (1.67) | 1 (3.33) | 0 (0.00) |
Cerebrovascular events | 2 (3.33) | 0 (0.00) | 2 (6.67) |
Previous valvuloplasty | 1 (1.67) | 0 (0.00) | 1 (3.33) |
Congestive heart failure | 1 (1.67) | 1 (3.33) | 0 (0.00) |
Etiology, n (%) | |||
Rheumatic | 33 (55.00) | 11 (36.67) | 22 (73.33) |
Degenerative | 27 (45.00) | 19 (63.33) | 08 (26.67) |
Concomitant procedures, n (%) | 20 (100) | 10 (50.00) | 10 (50.00) |
Coronary artery bypass grafts | 7 (35.00) | 4 (40.00) | 3 (30.00) |
Mitral valve repair | 3 (15) | 3 (30.00) | 0 (0.00) |
Tricuspid valve repair | 7 (35.00) | 0 (0.00) | 7 (70.00) |
Aortic root enlargement | 2 (10.00) | 2 (20.00) | 0 (0.00) |
Ascending aorta replacement | 1 (5.00) | 1 (10.00) | 0 (0.00) |